Concepedia

Doubling epirubicin dose intensity (100 mg/m2 versus 50 mg/m2) in the FEC regimen significantly increases response rates. An international randomised phase III study in metastatic breast cancer

G Brufman, E Colajori, N. Ghilezan, M. Lassus, Monica Martoni, C. Tosello, Donatella Viaro, C. Zielinski

Annals of Oncology · 1997 · 79 citations · 21 references

DOIFull text

Open access

Concepts

References

21

Reporting results of cancer treatment

A. B. Miller, Barth Hoogstraten, M. Staquet et al. · Cancer · 1981 · 7.9K citations

, , +16

Cancer statistics, 1995

Phyllis A. Wingo, T. Tong, S. Bolden · CA A Cancer Journal for Clinicians · 1995 · 1.4K citations · Full text

, , +17

Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation.

Harvey Schipper, Jennifer Clinch, Anne McMurray et al. · Journal of Clinical Oncology · 1984 · 1.1K citations

, , +17

Introduction to sample size determination and power analysis for clinical trials

John M. Lachin · Controlled Clinical Trials · 1981 · 1K citations

, , +13

Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer.

Philip Greenberg, Gabriel N. Hortobágyi, Terry L. Smith et al. · Journal of Clinical Oncology · 1996 · 754 citations

, , +11